063160.KS
CKD Bio Corp.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 13,600.00
−0.95%Margins
Gross margin
8.6%
EBITDA margin
5.4%
EBIT margin
-5.1%
Net margin
-6.8%
FCF margin
-6.2%
-9.0%
Return on equity
-3.7%
Return on assets
-3.0%
Return on invested capital
0.53x
Asset turnover
KRW 1.0B
Cash from operations
KRW 107
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026